Cadrenal Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Ponte Vedra, FL
SEC filing record 1 source field available
Fiscal year end
31 December
Cadrenal Therapeutics, Inc. has filed 269 SEC EDGAR filings since 15 Jul 2022

SEC filing history

Showing 51-75 of 269 matching filings.

Per page
25
Current page
3
4

4 filing

Filing date
31 Dec 2025
Reporting date
29 Dec 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD File 333-292444

UPLOAD filing

Filing date
31 Dec 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
30 Dec 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-41596

144 filing

Filing date
29 Dec 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1 File 333-292444

REGISTRATION STATEMENT

Filing date
29 Dec 2025
Reporting date
Not listed
Next action
Verify source filing
8-K File 001-41596

CURRENT REPORT

Filing date
23 Dec 2025
Reporting date
23 Dec 2025
Next action
Verify source filing
424B5 File 333-277835

PROSPECTUS SUPPLEMENT

Filing date
23 Dec 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-41596

CURRENT REPORT

Filing date
16 Dec 2025
Reporting date
15 Dec 2025
Next action
Verify source filing
424B5 File 333-277835

PROSPECTUS SUPPLEMENT

Filing date
16 Dec 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-277835

PROSPECTUS SUPPLEMENT

Filing date
16 Dec 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-41596

CURRENT REPORT

Filing date
11 Dec 2025
Reporting date
10 Dec 2025
Next action
Verify source filing
4

4 filing

Filing date
03 Dec 2025
Reporting date
02 Dec 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
03 Dec 2025
Reporting date
24 Nov 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-41596

CURRENT REPORT

Filing date
01 Dec 2025
Reporting date
24 Nov 2025
Next action
Verify source filing
8-K File 001-41596

CURRENT REPORT

Filing date
18 Nov 2025
Reporting date
18 Nov 2025
Next action
Verify source filing
424B5 File 333-277835

PROSPECTUS SUPPLEMENT

Filing date
18 Nov 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-41596

CURRENT REPORT

Filing date
10 Nov 2025
Reporting date
10 Nov 2025
Next action
Verify source filing
10-Q File 001-41596

QUARTERLY REPORT

Filing date
10 Nov 2025
Reporting date
30 Sep 2025
Next action
Verify source filing
4

4 filing

Filing date
28 Oct 2025
Reporting date
24 Oct 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
28 Oct 2025
Reporting date
24 Oct 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-41596

144 filing

Filing date
27 Oct 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-41596

144 filing

Filing date
27 Oct 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-41596

144 filing

Filing date
24 Oct 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-41596

144 filing

Filing date
24 Oct 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
14 Oct 2025
Reporting date
09 Oct 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .